tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 111 are a BUY (84.09%), 21 are a HOLD (15.91%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 17.2% that have a potential upside of 50.09% achieved within 52 days.
Emily Bodnar’s has documented 271 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OLMA, Olema Pharmaceuticals at 13-Nov-2024.
Analyst best performing recommendations are on NVCR (NOVOCURE LTD).
The best stock recommendation documented was for VTYX (VENTYX BIOSCIENCES) at 9/1/2022. The price target of $36 was fulfilled within 11 days with a profit of $14.01 (63.71%) receiving and performance score of 57.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$48
$0.45 (0.95%)
$48
1 years 3 months 11 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
$56
1 years 4 months 25 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$68
1 years 5 months ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$38
1 years 5 months ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
1 years 5 months ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
